 |
|
Intravitreal Dexamethasone Implantation in Intravitreal Bevacizumab Treatment-resistant Pseudophakic Cystoid Macular Edema
Ayse Gul Kocak Altintas, Cagri Ilhan
Korean J Ophthalmol. 2019;33(3):259-266. Published online 2019 Jun 4 DOI: https://doi.org/10.3341/kjo.2018.0106
|
|
Citations to this article as recorded by
 Current management options for the treatment of refractory postoperative cystoid macular edema: A systematic review
Layla J. Bunjo, Stephen Bacchi, James Pietris, Weng Onn Chan
Survey of Ophthalmology.2024;[Epub] CrossRef Pseudophakic macular edema in nondiabetic and diabetic patients without diabetic retinopathy treated with intravitreal dexamethasone implant
Magna Vanessa Rodrigues, Jose Mauricio Botto Garcia, Katia Delalibera Pacheco, Fabricio Tadeu Borges, David Leonardo Cruvinel Isaac, Marcos Avila
International Journal of Retina and Vitreous.2023;[Epub] CrossRef Current Management Options in Irvine–Gass Syndrome: A Systemized Review
Michał Orski, Maciej Gawęcki
Journal of Clinical Medicine.2021; 10(19): 4375. CrossRef Current role of intravitreal injections in Irvine Gass syndrome-CRIIG study
Ashish Sharma, Francesco Bandello, Anat Loewenstein, Baruch D. Kuppermann, Paolo Lanzetta, Dinah Zur, Assaf Hilely, Matias Iglicki, Daniele Veritti, Angeline Wang, Fernando Miassi, David Bellocq, Leandro Cabral Zacharias, Deepika Makam, Nilesh Kumar, Niku
International Ophthalmology.2020; 40(11): 3067. CrossRef Clinical Course of Pseudophakic Cystoid Macular Edema Treated with Nepafenac
Alexander Aaronson, Asaf Achiron, Raimo Tuuminen
Journal of Clinical Medicine.2020; 9(9): 3034. CrossRef
|